DOUGLAS CHARLES MACLELLAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DOUGLAS CHARLES MACLELLAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DOUGLAS CHARLES MACLELLAN. DOUGLAS CHARLES MACLELLAN is Chief Executive Officer in RADIENT PHARMACEUTICALS Corp ($RXPC) and Director in RADIENT PHARMACEUTICALS Corp ($RXPC) and Director in AXM PHARMA INC ($AXMA) and Director in OCEAN SMART, INC. ($EDWT) and Director in ChinaNet Online Holdings, Inc. ($CNET) and Director in Star Mountain Resources, Inc. ($SMRS) and Director in Oroplata Resources, Inc. ($ORRP).
Latest Insider Trading Transactions of DOUGLAS CHARLES MACLELLAN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ORRP, EDWT, AXMA, RXPC, SMRS, CNET
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 11 2021 | ORRP | AMERICAN BATTERY M ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 2.39 | 200,000 | 478,200 | 9,264,717 | 9.5 M to 9.3 M (-2.11 %) |
Jun 11 2021 | ORRP | AMERICAN BATTERY M ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 2.32 | 200,000 | 463,600 | 9,414,717 | 9.6 M to 9.4 M (-2.08 %) |
Apr 02 2021 | ORRP | AMERICAN BATTERY M ... | MACLELLAN DOUGLAS CHARLES | Director | Grant | A | 0.00 | 4,717 | 0 | 10,014,717 | 10 M to 10 M (+0.05 %) |
Jan 11 2021 | ORRP | AMERICAN BATTERY M ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 1.20 | 20,000 | 24,046 | 10,010,000 | 10 M to 10 M (-0.20 %) |
Jan 11 2021 | ORRP | AMERICAN BATTERY M ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 1.13 | 20,000 | 22,608 | 10,030,000 | 10.1 M to 10 M (-0.20 %) |
Jan 07 2021 | ORRP | AMERICAN BATTERY M ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 0.96 | 20,000 | 19,288 | 10,150,000 | 10.2 M to 10.2 M (-0.20 %) |
Jan 07 2021 | ORRP | AMERICAN BATTERY M ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 0.96 | 20,000 | 19,146 | 10,170,000 | 10.2 M to 10.2 M (-0.20 %) |
Dec 15 2020 | ORRP | AMERICAN BATTERY M ... | MACLELLAN DOUGLAS CHARLES | Director | Grant | A | 0.00 | 1,000,000 | 0 | 10,190,000 | 9.2 M to 10.2 M (+10.88 %) |
Jun 11 2020 | ORRP | AMERICAN BATTERY M ... | MACLELLAN DOUGLAS CHARLES | Director | Grant | A | 0.10 | 10,000 | 970 | 9,190,000 | 9.2 M to 9.2 M (+0.11 %) |
Mar 02 2020 | ORRP | AMERICAN BATTERY M ... | MACLELLAN DOUGLAS CHARLES | Director | Grant | A | 0.00 | 2,000,000 | 0 | 9,200,000 | 7.2 M to 9.2 M (+27.78 %) |
Mar 02 2020 | ORRP | AMERICAN BATTERY M ... | MACLELLAN DOUGLAS CHARLES | Director | Grant | A | 0.00 | 1,000,000 | 0 | 7,200,000 | 6.2 M to 7.2 M (+16.13 %) |
Feb 20 2019 | ORRP | Oroplata Resources ... | MACLELLAN DOUGLAS CHARLES | Director | Grant | A | 0.00 | 2,000,000 | 0 | 6,200,000 | 4.2 M to 6.2 M (+47.62 %) |
Oct 15 2018 | ORRP | Oroplata Resources ... | MACLELLAN DOUGLAS CHARLES | Director | Grant | A | 0.00 | 1,000,000 | 0 | 4,200,000 | 3.2 M to 4.2 M (+31.25 %) |
Oct 15 2018 | ORRP | Oroplata Resources ... | MACLELLAN DOUGLAS CHARLES | Director | Grant | A | 0.00 | 1,200,000 | 0 | 3,200,000 | 2 M to 3.2 M (+60.00 %) |
Oct 15 2018 | ORRP | Oroplata Resources ... | MACLELLAN DOUGLAS CHARLES | Director | Grant | A | 0.00 | 2,000,000 | 0 | 2,000,000 | 0 to 2 M |
Sep 30 2015 | SMRS | Star Mountain Reso ... | MACLELLAN DOUGLAS CHARLES | Director | Grant | A | 0.00 | 50,000 | 0 | 175,000 | 125 K to 175 K (+40.00 %) |
May 19 2015 | SMRS | Star Mountain Reso ... | MACLELLAN DOUGLAS CHARLES | Director | Grant | A | 0.00 | 50,000 | 0 | 125,000 | 75 K to 125 K (+66.67 %) |
Apr 21 2015 | CNET | ChinaNet Online Ho ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 0.00 | 50,000 | 0 | 0 | 50 K to 0 (-100.00 %) |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 0.75 | 200,000 | 150,000 | 446,000 | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 0.75 | 90,000 | 67,500 | 246,000 | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 0.75 | 120,000 | 90,000 | 156,000 | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 0.75 | 36,000 | 27,000 | 36,000 | |
Oct 19 2009 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | J | 0.00 | 200,000 | 0 | 1,100 | 201.1 K to 1.1 K (-99.45 %) |
Jan 09 2009 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Chief Executive Off ... | Grant | A | 0.72 | 200,000 | 144,000 | 201,100 | 1.1 K to 201.1 K (+18,181.82 %) |
Oct 15 2008 | EDWT | OCEAN SMART, INC. | MACLELLAN DOUGLAS CHARLES | Director | Buy | P | 0.10 | 15,000 | 1,500 | 1,260,000 | 1.2 M to 1.3 M (+1.20 %) |
Oct 15 2008 | EDWT | OCEAN SMART, INC. | MACLELLAN DOUGLAS CHARLES | Director | Buy | P | 0.10 | 5,000 | 500 | 1,245,000 | 1.2 M to 1.2 M (+0.40 %) |
Jul 16 2008 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Buy | P | 2.68 | 1,000 | 2,684 | 1,100 | 100 to 1.1 K (+1,000.00 %) |
Mar 31 2008 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 3.45 | 200,000 | 690,000 | 485,000 | |
Sep 07 2007 | EDWT | OCEAN SMART, INC. | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 1.21 | 200,000 | 242,000 | 200,000 | |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | M | 2.40 | 13,000 | 31,200 | 285,000 | |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.86 | 300 | 1,158 | 0 | 300 to 0 (-100.00 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.80 | 1,700 | 6,460 | 300 | 2 K to 300 (-85.00 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.79 | 125 | 474 | 2,000 | 2.1 K to 2 K (-5.88 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.78 | 875 | 3,308 | 2,125 | 3 K to 2.1 K (-29.17 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.76 | 200 | 752 | 3,000 | 3.2 K to 3 K (-6.25 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.75 | 500 | 1,875 | 3,200 | 3.7 K to 3.2 K (-13.51 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.74 | 300 | 1,122 | 3,700 | 4 K to 3.7 K (-7.50 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.71 | 300 | 1,113 | 4,000 | 4.3 K to 4 K (-6.98 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.70 | 2,200 | 8,140 | 4,300 | 6.5 K to 4.3 K (-33.85 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.66 | 500 | 1,830 | 6,500 | 7 K to 6.5 K (-7.14 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.65 | 300 | 1,095 | 7,000 | 7.3 K to 7 K (-4.11 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.62 | 500 | 1,810 | 7,300 | 7.8 K to 7.3 K (-6.41 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.60 | 1,600 | 5,760 | 7,800 | 9.4 K to 7.8 K (-17.02 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.58 | 200 | 716 | 9,400 | 9.6 K to 9.4 K (-2.08 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.57 | 600 | 2,142 | 9,600 | 10.2 K to 9.6 K (-5.88 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.56 | 600 | 2,136 | 10,200 | 10.8 K to 10.2 K (-5.56 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.55 | 500 | 1,775 | 10,800 | 11.3 K to 10.8 K (-4.42 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.54 | 500 | 1,770 | 11,300 | 11.8 K to 11.3 K (-4.24 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Sell | S | 3.53 | 1,200 | 4,236 | 11,800 | 13 K to 11.8 K (-9.23 %) |
Jun 28 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Buy | M | 2.40 | 13,000 | 31,200 | 13,000 | 0 to 13 K |
Jun 11 2007 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 4.06 | 90,000 | 365,400 | 90,000 | |
Oct 12 2004 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 0.93 | 55,000 | 51,150 | 55,000 | |
Apr 15 2004 | AXMA | AXM PHARMA INC | MACLELLAN DOUGLAS CHARLES | Director | Sell | P | 5.08 | 10,171 | 51,669 | 38,329 | 48.5 K to 38.3 K (-20.97 %) |
Mar 15 2004 | AXMA | AXM PHARMA INC | MACLELLAN DOUGLAS CHARLES | Director | Sell | P | 6.55 | 7,500 | 49,122 | 48,500 | 56 K to 48.5 K (-13.39 %) |
Mar 15 2004 | AXMA | AXM PHARMA INC | MACLELLAN DOUGLAS CHARLES | Director | Sell | P | 6.76 | 34,000 | 229,728 | 56,000 | 90 K to 56 K (-37.78 %) |
Feb 11 2004 | AXMA | AXM PHARMA INC | MACLELLAN DOUGLAS CHARLES | Director | Sell | P | 5.73 | 10,387 | 59,518 | 10,172 | 20.6 K to 10.2 K (-50.52 %) |
Feb 11 2004 | AXMA | AXM PHARMA INC | MACLELLAN DOUGLAS CHARLES | Director | Sell | P | 5.73 | 10,387 | 59,518 | 10,172 | 20.6 K to 10.2 K (-50.52 %) |
Feb 25 2004 | RXPC | RADIENT PHARMACEUT ... | MACLELLAN DOUGLAS CHARLES | Director | Option Exercise | A | 1.23 | 100,000 | 123,000 | 100,000 |
Page: 1